Longer follow-up presented at the 2026 ESMO Congress showed that four already-approved treatments for early breast cancer, kidney cancer, colorectal cancer and stomach and esophageal cancer kept ...

A clinical trial will test zanubrutinib plus sonrotoclax as a fixed-duration, chemotherapy-free treatment for hairy cell ...

C, discusses why he built the MyUrova app and how men with prostate, bladder, kidney or testicular cancer can prepare for ...

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.

Two phase 3 trials at ESMO 2026 brought new options for advanced endometrial cancer, and final results for Verzenio after another CDK4/6 drug showed a survival difference that was not statistically ...

Four phase 3 trials at ESMO 2026 brought news for people with small cell, EGFR, MET and KRAS G12C lung cancer, plus a caution ...

Kreitman of the National Cancer Institute has spent more than three decades working on hairy cell leukemia (HCL). He first encountered the disease in 1983 as a medic ...

Be The Match® is a community of donors, volunteers, health care professionals and researchers who deliver cures by helping patients get the life-saving marrow or umbilical cord blood transplant they ...

Testicular cancer survivor Brian Sluga shares how faith, journaling and new goals, like training for marathons, helped him ...

Five phase 3 trials presented at ESMO 2026 showed new options in small cell lung, bladder, prostate, KRAS G12C lung and ...

An expert discusses infection risks after treatment, what follow-up care looks like and why patients with a rare cancer ...

For patients with hairy cell leukemia whose cancer returns after multiple treatments, researchers are investigating whether ...